However, a study assessing CNVs in ErbB genes found that half of all lung adenocarcinomas have CNVs of EGFR, ERBB2, ERBB3 and ERBB4, with higher CNV number corresponding to poorer prognosis (56). This evidence concerns the gene ERBB2 and lung adenocarcinoma.